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Tubes with distinct shapes and sizes are critical for the proper function of many tubular organs. Here we
describe a unique phenotype caused by the loss of a novel, evolutionarily-conserved, Drosophila Smad-
like protein, Expansion. In expansion mutants, unicellular and intracellular tracheal branches develop
bubble-like cysts with enlarged apical membranes. Cysts in unicellular tubes are enlargements of the
apical lumen, whereas cysts in intracellular tubes are cytoplasmic vacuole-like compartments. The cyst
phenotype in expansion mutants is similar to, but weaker than, that observed in double mutants of
Drosophila type III receptor tyrosine phosphatases (RPTPs), Ptp4E and Ptp10D. Ptp4E and Ptp10D
negatively regulate the receptor tyrosine kinase (RTK) pathways, especially epithelial growth factor
receptor (EGFR) and ﬁbroblast growth factor receptor/breathless (FGFR, Btl) signaling to maintain the
proper size of unicellular and intracellular tubes. We show Exp genetically interacts with RTK signaling,
the downstream targets of RPTPs. Cyst size and number in expansion mutants is enhanced by increased
RTK signaling and suppressed by reduced RTK signaling. Genetic interaction studies strongly suggest
that Exp negatively regulates RTK (EGFR, Btl) signaling to ensure proper tube sizes. Smad proteins
generally function as intermediate components of the transforming growth factor-β (TGF-β, DPP)
signaling pathway. However, no obvious genetic interaction between expansion and TGF-β (DPP)
signaling was observed. Therefore, Expansion does not function as a typical Smad protein. The expansion
phenotype demonstrates a novel role for Smad-like proteins in epithelial tube formation.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Branched tubular organs such as the lung, vascular system, and
kidney are essential for transporting oxygen, nutrients, and cells in
all multicellular organisms. The optimal ﬂow of transported ﬂuids
depends on the uniform length and diameter of the tubes.
Aberrant tube sizes that arise during development lead to devas-
tating human illnesses, such as polycystic kidney disease and
blood vessel stenosis (Lubarsky and Krasnow, 2003). While the
early patterning and branching of tubular networks have been
studied extensively in several systems (Horowitz and Simons,
2008; Lu and Werb, 2008; Andrew and Ewald, 2010), the cellular
and molecular mechanisms of tube-size regulation remain poorly
understood.
The Drosophila trachea is a ramifying network of epithelial
tubes with the apical surfaces facing the lumen and the basal
surfaces facing surrounding tissues. The fully developed trachea
consists of four types of tubes that differ in sizes and architecture
(Samakovlis et al., 1996). Type I tubes are multicellular, such as the
dorsal trunk (DT) and majority of the transverse connective (TC).
In these tubes, several cells are connected by intercellular junc-
tions and surround an extracellular central lumen. The narrower
Type II tubes are unicelluar, such as the lateral trunk (LT), gang-
lionic branch (GB), dorsal branch (DB), and visceral branch (VB).
These tubes are comprised of a linear arrangement of single cells
whose apical surfaces surround an extracellular lumen. Cells of
unicellular tubes connect themselves around the lumen with
autocellular junctions. Type III tubes are intracellular tubes to
connect neighboring branches. In these tubes, two donut shaped
cells arrange in a linear head-to-tail conﬁguration, and their apical
surfaces span the inner wall of the donut, resulting in seamless
tubes without intracellular junctions. Type IV tubes are highly
branched intracellular cytoplasmic extensions that form in term-
inal cells at the tips of the unicellular tubes, such as the lateral
ganglionic branch (LG).
Tracheal tube size is tightly linked to branch identity, and each
tube has a distinct width and length. The speciﬁcation of tracheal
tubes initially depends on signaling pathways, including the Epi-
dermal Growth Factor (EGF; Spitz), Transforming Growth Factor-β
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(TGF-β; Decapentaplegic), andWingless (Wg) pathways (Chen et al.,
1998; Llimargas and Casanova, 1999). This initial speciﬁcation is
followed by Fibroblast Growth Factor (FGF; Branchless) signaling,
which directs the migration of tracheal cells in stereotypical
directions to form distinct branches. Once branches are formed,
tube size is modiﬁed by changes along the apical side of the tracheal
cells (Beitel and Krasnow, 2000).
The chitin-based apical luminal matrix, cell junctions, apical
secretion, as well as endocytosis have been implicated in tube-size
regulation. Mutations disrupting chitin biosynthesis (krotzkopf
verkehrt and mummy/cystic) and matrix assembly (knickkopf
and retroactive) grow over-dilated tubes (Araujo et al., 2005;
Devine et al., 2005; Moussian et al., 2006). In contrast, mutations
affecting chitin modiﬁcation (vermiform and serpentine) (Luschnig
et al., 2006) and septate junctions (SJ, analogous to vertebrate tight
junctions) lead to longer tubes (Behr et al., 2003; Paul et al., 2003;
Llimargas et al., 2004; Wu et al., 2004; Luschnig et al., 2006;
Moyer and Jacobs, 2008; Laprise et al., 2010). In addition, defects in
the general apical secretion pathway cause narrower tubes
(Jayaram et al., 2008; Norum et al., 2010), whereas loss of function
mutations in the endocytosis pathway show over-dilated tubes
(Behr et al., 2007). Current knowledge in mechanisms of tube size
regulation discussed above is mostly revealed in multicellular
dorsal trunk studies.
Literature on terminal branch (intracellular tube) morphology
and size control has recently grown rapidly. Terminal branch
development contains ﬁve major morphogenesis and maturation
steps: branching, growth, tubulogenesis, gas-ﬁlling, and mainte-
nance. A systematic screen revealed that cytoskeletal and secre-
tory pathways play important roles in terminal branch
morphogenesis (Ghabrial et al., 2011). For example, both Whacked
and Rab35-mediated minus-end directed transport of apical
membrane components, as well as exocyst-mediated membrane
trafﬁcking are required for seamless tube outgrowth
(Schottenfeld-Roames and Ghabrial, 2012; Jones et al., 2014). Loss
of function of wheezy, which encodes a germinal center kinase,
results in terminal branch over-dilation, partially through enriched
Rab11-mediated trafﬁcking of the apical membrane protein
Crumbs (Song et al., 2013). Different types of tubes might employ
some similar mechanisms to regulate tube size; however, as tube
structures vary, branch-speciﬁc mechanisms likely exist.
In this paper, we describe the role of Drosophila Expansion (Exp,
CG13188), a novel Smad-like protein in tube-size regulation. exp
mutants develop bubble-like cysts in unicellular and intracellular, but
not multicellular tubes, suggesting that exp is required for branch
speciﬁc tube-size regulation. Smad proteins are generally known as
intracellular mediators of TGF-β signaling (Shi, 2001). TGF-β signal-
ing controls cranial vessel size in zebraﬁsh by regulating cell number
(Roman et al., 2002), and it also regulates Drosophila tracheal branch
speciﬁcation and migration (Chen et al., 1998). However, both branch
identity and cell number were not changed in exp mutants.
In addition, the loss or gain of function in Drosophila TGF-β
signaling mutants have no obvious tube-size defects (Chen et al.,
1998; Myat et al., 2005). Therefore, exp may not function as a
mediator of TGF-β signaling like a typical Smad. Interestingly, the
unique exp phenotype has not been discovered in any genetic screens
for tube-size defects. A similar phenotype was only discovered in
double mutants of Type III receptor protein tyrosine phosphatases
(RPTPs), Ptp4EPtp10D (Jeon et al., 2008). These are the only two Type
III RPTPs in Drosophila (Jeon et al., 2008).
Studies have suggested that Type III RPTPs are negative regulators
of the receptor tyrosine kinases (RTKs) that work by dephosphor-
ylating the RTKs and their substrates (Tonks, 2006; Matozaki et al.,
2010). Upon ligand binding and phosphorylation, the kinase activity
of RTK phosphorylates downstream effectors to transmit signals.
In the Drosophila trachea, these are found as: EGFR (epidermal growth
factor receptor), Btl (ﬁbroblast growth factor receptor ortholog
Breathless), and Pvr [the platelet-derived growth factor receptor
(PDGFR)/vascular-endothelial growth factor receptor (VEGFR)/colony
stimulating factor 1 (CSF1R)] (Glazer and Shilo, 1991; Cho et al., 2002;
Cela and Llimargas, 2006). MAP kinase and Rho pathways are the two
well-known downstream pathways of RTKs (Brand and Perrimon,
1994; Schiller, 2006). Genetic interaction studies suggest that over-
active RTKs (especially EGFR and Btl), and the downstream MAP
kinase and Rho pathways, contribute to the cyst phenotype observed
in Ptp4EPtp10D double mutants in the Drosophila trachea (Jeon and
Zinn, 2009; Jeon et al., 2012).
To test the idea that Exp regulates tube size using a similar
mechanism as RPTPs, we examined genetic interactions between
Exp and components of the RTK signaling pathways (EGFR, Btl,
MAP kinase, and Rho GTPase). We decreased or increased RTK
signaling by expressing dominant negative (DN) and constitutively
active (CA) constructs of these components in the trachea in an exp
mutant background, and then analyzed their effects on the cyst
phenotype. Activating RTK signaling enhanced the cyst phenotype
in exp mutants whereas inhibiting RTK signaling reduced the cyst
phenotype. Our results strongly suggest that Exp functions as a
negative regulator of RTK signaling to control tube size in
unicellular and intracellular branches. The functional analysis of
this novel Smad protein reveals a previously unidentiﬁed role for
Smad family proteins in regulating RTK signaling to control
epithelial tube formation.
Material and methods
Drosophila strains
We used w1118 as the wild-type control strain. To generate exp
mutants, 100 y w; EP[PI31G7971] virgin females were crossed to 100
jump starter y w; P[wþ ; Δ2–3] males. Resulting F1 w; EP
[PI31G7971]/P[wþ; Δ2–3] males (200) were crossed to y w; Pin/
CyO virgin females (200). Individual white-eyed males from the F2
generation (400) were selected and backcrossed to y w; Pin/CyO P
[wþ; twi–GFP] females to establish stocks. We tested 400 jump-
out lines for failure to complement Df(2R)BSC879 [48C5-48E2],
which is deleted for exp [48D3-D5]. We sequenced genomic DNA
PCR ampliﬁed from mutant alleles to determine the deletion
breakpoints. Two exp null mutant alleles were isolated: exp135
and exp11. Homozygous mutant individuals were identiﬁed in
genetic experiments by the absence of GFP expression from CyO
P[wþ; twi–GFP]. The following Drosophila strains were also used: y
w; P[wþ; btl-Gal4] (Klambt et al., 1992) to drive various tracheal
speciﬁc UAS expression. The following Drosophila stocks were
obtained from the Bloomington Stock Center: UAS-EgfrElp, UAS-
Egfr-DN, UAS-PhI-CA, UAS-Rho1V14, UAS-Rho1N19, UAS-Rac1V12,
UAS-Rac1N17, UAS-Cdc42V12, UAS-Cdc42N17, punt135. UAS-λBtl,
UAS-Btl-DN, btl-Gal4 were provided by M. Krasnow (Stanford
University, Stanford, CA, USA), and UAS-TKVQ253D was provided
by MM. Myat (Weill Cornell Medical College, NY, USA).
Ptp4E1Ptp10D1/FM7-GFP;Btl-Gal4 line was provided by K. Zinn
(California Institute of Technology, CA, USA).
Generation of expansion cDNA clones
Total RNA from an overnight collection of Drosophila embryos
was extracted using an RNAeasy Mini Kit (Qiagen). Poly(A)þ mRNA
was extracted from total RNA using Oligotex (Qiagen). First-strand
cDNA was synthesized using SuperScript reverse transcriptase
(Gibco-BRL) and used as a template for PCR. Two pairs of primers
predicted to cover the cDNA of exp isoforms A and B were utilized:
(A Forward: 50-ATGGTGTCGCGTCGAAAAATTCTATCACG-30 and A
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Reverse: 50-TTAGTAGTCGAGTATTTGGATTTTCTTCAGGCTG-30; B For-
ward: 50-ATGGTGTCGCGTCGAAAAATTCTATCACG-30 and B Reverse:
50-TCAGTCCCATTCCCCGATGAA-30). exp-A encodes a fragment of
3078 bp, and exp-B codes a fragment of 1542 bp. The ampliﬁed
fragments were cloned into pCR2.1 (Invitrogen) and sequenced.
Generation of UAS HA-tagged exp transgenic strains
To generate HA-tagged exp fragments, exp-A and exp-B cDNA
fragments without the ATG start codon were PCR ampliﬁed and
cloned into pCR8/GW/TOPO (Invitrogen). The inserts were then
cloned into pAHW, a HA-tag-containing Gateway compatible vector
(http://www.ciwemb.edu/labs/murphy), using Gateway LR Clonase II
plus (Invitrogen). HA-exp-A and HA-exp-B were then PCR-ampliﬁed
and cloned into pCR8/GW/TOPO. The following primers were used:
HA-exp-A Forward: 50-GTGTCGCGTCGAAAAATTCTATCACG-30 and A
Reverse: 50-TTAGTAGTCGAGTATTTGGATTTTCTTCAGGCTG-30 HA-exp-
B Forward: 50-GTGTCGCGTCGAAAAATTCTATCACG-30 and B Reverse:
50-TCAGTCCCATTCCCCGATGAA-30. Inserts were then cloned into the
P element vector pT (http://www.ciwemb.edu/labs/murphy), a Dro-
sophila Gateway-compatible vector that carries an upstream UAS
sequence, using Gateway LR Clonase II. The UAS-HA-exp transgenes
were introduced into the Drosophila germline by microinjection.
Drosophila in situ hybridization
Drosophila whole-mount embryos were hybridized in situ to a
Drosophila exp antisense RNA probe. The probes that recognize
both exp isoforms or only the exp-A isoform were generated by
PCR ampliﬁcation of the exp cDNA fragments. The PCR product was
cloned into PCRII-TOPO, and the digoxigenin (DIG)-labeled RNA
probes were synthesized using SP6 RNA polymerase (Promega) at
37 1C for 3 h. The probe was added to the hybridization buffer [50%
deionized formamide, 5 SSC (1 SSC is 0.15 M NaCl plus 0.015 M
sodium citrate), 100 μg/ml of sonicated, denatured salmon sperm
DNA, 100 μg/ml of Escherichia coli tRNA, 50 μg/ml of heparin, 0.1%
Tween 20, pH 4.5]. Hybridization was carried out for 16 h at 55 1C.
After a washing step, hybridized embryos were blocked in 0.5%
blocking buffer (Perkin Elmer) and incubated in anti-dig-POD
antibody (Roche) diluted 1:50 in 0.5% blocking buffer for 1 h.
Following three 10 min PT (PBS, 0.1% Tween-20) washes, embryos
were incubated for 1 h in TSA-Cy3 diluted in ampliﬁcation diluent
(Perkin Elmer). TSA reactions were stopped by three 5 min PT
washes. Embryos were mounted in 70% glycerol and examined by
confocal microscopy.
Exp antibody production
Polyclonal antibodies against Exp were generated by using an
Exp fusion protein containing an N-terminal His6-tag. An exp
fragment corresponding to amino acids (aa) 233–477 of exp-B
was PCR ampliﬁed using the primers: 50-CTCGAGAAGAG-
CAAACTGCCACCAGTG-30 and 50-CTCGAGGTCCCATTCCCCGATGAA-
CATG-30 (the XhoI restriction sites are underlined), then digested
with XhoI, and cloned into the XhoI site of pET-16b (Novagen).
After transformation into E. coli BL21(DE3), cells were grown and
His6-Exp fusion protein synthesis was induced by addition of IPTG
(isopropyl-β-D-thiogalactopyranoside). Inclusion bodies were pre-
pared, solubilized in 10% sodium dodecyl sulfate (SDS), dialyzed in
0.05% SDS, 1 mM phenylmethylsulfonyl ﬂuoride, PBS, and puriﬁed
using a Talon metal afﬁnity resin (Clontech). The eluted His6-Exp
protein was then dialyzed in 0.01% SDS, PBS. Two guinea pigs were
immunized by subcutaneous injection of protein (Pocono Rabbit
Farm & Laboratory).
Western blot
To prepare protein extracts, 50 Drosophila embryos of wild type
w1118 and exp135 between S14 and S17 were homogenized and
treated with 50 μl protein extraction lysate buffer (1 M Tris pH 8.2,
5 M NaCl, 10% SDS, 10% SDC, 100% NP40, 100 mM PMSF, protease
inhibitor) respectively. The homogenate was centrifuged at
15,000 g for 5 min at 4 1C, and the supernatant was further
centrifuged with glycerol at 15,000 g for 5 min at 4 1C to pre-
cipitate the crude membrane fraction. Protein concentration of the
supernatant was then measured using the Coomassie assay. Cell
lysates were heated to 100 1C, an SDS sample buffer was added,
and the lysates were separated on an 8% gel by SDS-PAGE,
transferred to a polyvinylidene diﬂuoride membrane, and sub-
jected to immunoblotting with anti-Exp (1:1000 dilution). Next,
the same membrane was washed with stripping buffer and
subjected to immunobloting with anti-β-actin. The immunoblot
was developed with Western Lightning reagents (Perkin Elmer)
according to the manufacturer's recommendation.
Drosophila immunostaining
Whole-mount embryos were immunostained as described
previously (Patel et al., 1987). The following primary antibodies
and dilutions were used for immunostaining: anti-Exp (Guinea Pig
1:200), anti-Trh (rat 1:100) (Ward et al., 1998), anti-GFP (chicken
1:500, Abcam), anti-RFP (rabbit 1:500, Abcam), anti-Crumbs
(mouse 1:100, DSHB), MAb 2A12 (mouse IgM 1:5, DSHB), anti-
DE-Cadherin (rat 1:3, DSHB), anti-Coracle (Guinea Pig 1:2000)
(Lamb et al., 1998), anti-Verm (Rabbit 1:100) (Luschnig et al.,
2006), anti-Rip11 (rabbit 1:100) (Li et al., 2007), anti-uninﬂatable
(Uif) (Guinea Pig 1:100) (Zhang and Ward, 2009), anti-HA (rabbit
1:100, Invitrogen). The following secondary antibodies were used:
(1) AlexaFluor 594 anti-mouse IgM, (2) AlexaFluor 543 anti-Rat
IgG, anti-Rabbit IgG, anti-Guinea Pig IgG, (3) AlexaFluor 488 anti-
Rat IgG, anti-rabbit IgG, and anti-Guinea Pig IgG, (4) AlexaFluor
647 anti-Rat IgG, anti-Rabbit IgG, and anti-Guinea Pig IgG (Invitro-
gen). All secondary antibodies were used at 1:200. Chitin-binding
probe was used at 1:50 (New England Biolabs). Photomicrographs
were taken with a Nikon Eclipse Ti confocal microscope.
RNAi
Double-stranded RNA (dsRNA) for RNA interference (RNAi)
experiments was prepared for exp using the same protocol as
described earlier (Jiang and Crews, 2003). The templates used for
synthesis of dsRNA were the products of two-step PCR. The ﬁrst
step ampliﬁed a fragment of cDNA that contains a partial T7 RNA
polymerase promoter site. The second PCR step ampliﬁed the
fragment and completed the addition of a T7 RNA polymerase site
adjacent to both ends of the cDNA sequence. The ﬁrst PCR used to
amplify exp cDNA utilized the following primer pair: 50-CGACT-
CACTATAGGGCTCGAGAAGAGCAAACTGCCACCAGTG-30 and 50-CGAC-
TCACTATAGGGCTCGAGGTCCCATTCCCCGATGAACATG-30 (the T7
sequences are underlined). This fragment is the same as the
fragment used to generate Exp antibody. The second step of the
PCR used the T7 promoter sequence (ATAGAATTCTCTAGAAGCT-
TAATACGACTCACTATAGGG) as a primer. This resulted in an ampli-
ﬁed fragment with T7 RNA polymerase sites at both ends, allowing
the simultaneous synthesis of sense and antisense RNA. DNA
templates were puriﬁed by using QIAquick PCR puriﬁcation kit
(Qiagen). dsRNAs were synthesized by using T7 RNA polymerase
and DNA templates were removed with RNase-free DNase. After
phenol–chloroform extraction and ethanol precipitation, the
dsRNAs were dissolved in Tris–EDTA (TE) at a ﬁnal concentration
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of 5 μM. Analysis of dsRNAs by agarose gel electrophoresis
indicated that bands of the expected sizes were present.
Quantiﬁcation of cyst phenotypes
Stage 16 embryos were stained with anti-Crumbs or anti-
Uninﬂatable to outline the apical membrane. Samples were
imaged using Nikon confocal microscopy and z-stack projections
were obtained. Measurements were made using the Nikon NLS
Elements program. Comparison of tracheal metameres (Tr5-8)
from mutant embryos showed little variation between hemiseg-
ments and thus measurements for all four hemisegments were
pooled; 10 embryos were scored per genotype. All spherical
enlargements along LT and GB were counted as cysts and dia-
meters were measured. For controls without LT and GB cysts, two
measurements were made at the thickest points of each LT and GB
branch.
Results
Identiﬁcation of the Drosophila expansion gene
To identify novel genes required for tube-size regulation, we
performed an RNAi knock down screen of ten novel tracheal
expressed genes according to the Berkeley Drosophila Genome
Project (BDGP) gene expression database (http://insitu.fruitﬂy.org/
cgi-bin/ex/insitu.pl). One of these genes, which we named exp
(CG13188), is required for tube-size regulation. Knocking down exp
by RNAi leads to bubble-like cysts (Fig. 1B, B0) with an enlarged
diameter in the trachea compared to wild type control (Fig. 1A, A0).
The exp gene resides at 48D3-D5 on chromosome 2 and produces
transcripts that encode two protein isoforms: Exp-A (1025 aa) and
Exp-B (513 aa) (Fig. 2A). Transcripts corresponding to the two
isoforms were conﬁrmed by RT-PCR and sequencing. Analysis of
the protein sequence indicates that Exp is a Smad-like protein
containing a Mad-homology 2 (MH2) domain (Fig. 2A). Smad
proteins are 400–500 amino acids in length, with particularly high
similarity in the N-terminal MH1 (Mad-homology 1) domain and
the C-terminal MH2 domain (Heldin et al., 1997). The MH2 domain
is responsible for interacting with other proteins, whereas the
MH1 domain exhibits sequence-speciﬁc DNA binding. Generally,
Smads are intracellular mediators of the TGF-β signaling pathway
(Shi, 2001). Smads that contain only the MH2 domain, such as the
daughters against DPP (Dad) protein, function as regulators of
TGF-β signaling (Tsuneizumi et al., 1997). Exp contains only an
MH2 domain, but no MH1 domain, indicating that it may poten-
tially act as a regulator of the TGF-β signaling pathway. However, it
is also possible that Exp does not act as a typical Smad protein and
regulates tube size through other signaling pathways or cellular
processes. Phylogenetic analysis of the MH2 domain of Exp shows
that it forms a subfamily with Drosophila CG13183 (Dro-CG13183),
Anopheles gambiae AGAP007416 (An-AGAP007416), and Caenor-
habditis elegans C34E11.2c (Ce-C34E11.2c). Furthermore, it is dis-
tantly related to human proteins Smad2 and BAH12971 (Fig. 2B).
Quantitatively, the MH2 region of Exp shows the following percent
identity and similarity to the other Exp subfamily proteins: Ano-
AGAP007416 91% (identity) and 98% (similarity), Dro-CG13183 63%
(identity) and 80% (similarity), Ce-C34E11.2c 39% (identity) and
54% (similarity). In addition, Exp is highly conserved in all twelve
Drosophila species, other insects, and arthropods.
Exp is localized throughout the cytoplasm in all tracheal cells
To visualize the protein localization of Exp in Drosophila
embryos, an antibody that recognizes both Exp isoforms was
generated. The Exp antisera were prepared against a bacteria-
synthesized Exp protein derived from a region of the protein not
conserved in other Smad proteins (Fig. 2A). Immunostaining of
whole-mount w1118 embryos revealed that the Exp protein was
localized in all tracheal cells from stage 12 through the end of
embryogenesis, stage 17 (Fig. 3B0–G0), but not at the tracheal
placode, stage 11 (Fig. 3A0). Staining in epidermal cells was also
observed at late stages of embryogenesis, stage 16–17 (arrowheads
in Fig. 3F0–G0). The expression pattern of the Exp protein is
identical to the exp RNA pattern revealed by ﬂuorescence in situ
hybridization (Fig. 3A–G), suggesting antibody speciﬁcity. An exp
probe that recognizes both isoforms was used (Fig. 2A). The
speciﬁcity of the Exp antisera was further demonstrated by an
absence of Exp staining in exp deletion strains (Df(2R)BSC879
[48C5-48E2]) (Fig. 3H) even though tracheal cells were present
(Fig. 3H0). To visualize cellular localization of Exp in the trachea,
membrane marker GAP-GFP was expressed in all tracheal cells and
nuclei were determined by a tracheal nuclear protein, Trachealess
(Trh) (Wilk et al. 1996). The cellular localization of the Exp protein
was observed throughout the cytoplasm (Fig. 3I, I″) but not in
nuclei (asterisks in Fig. 3I″). In addition, partial overlap between
Exp and the membrane marker GAP-GFP was also observed
(arrowhead in Fig. 3I). These results suggest that Exp functions
at the level of the cytoplasm and probably also membrane, but not
in the nucleus. Additionally, to reveal possible differential expres-
sion patterns of the two Exp isoforms, we performed in situ
hybridization using an exp-A probe that speciﬁcally recognizes
the longer form of exp (Fig. 2A). No tracheal staining was detected
(Fig. 3K), suggesting that the exp-A isoform is expressed at a very
low level below detection by in situ. Consistent with this, the
expected 138KD Exp-A was not detected in embryonic protein
extracts by Western blot analysis (Fig. 3J). We only detected Exp-B
protein (69 KD) in wild type embryos but not in exp null mutant
embryos (Fig. 3J). Therefore, the Exp-B isoform is the form
expressed in tracheal cells.
Generation of exp null mutants
To perform functional analysis of exp in tracheal tube-size
regulation, we generated exp null mutants. The P-element inser-
tion EP[PI31G7971] resides within the PI31 gene, which is located 30
downstream of exp. Mutants were generated by imprecise excision
of the P-element. The exp135 excision mutant (Fig. 4A) removed
exons 3-11 of the exp gene and potentially generates a severely
truncated protein (39 aa) that lacks the entire MH2 and C-terminal
domains (Fig. 2A). Moreover, this deletion also partially deletes the
neighboring PI31 gene. The exp11 mutant (Fig. 4A) removed the
entire coding sequence of exp (exons 2-11) and also deleted the
two neighboring genes, PI31 and CG8290. Another excision dele-
tion, Δ1, removed both PI31 and CG8290, while leaving the exp
locus intact. Immunostaining of mutant embryos revealed that in
homozygous exp135 (Fig. 4D) and exp11 (Fig. 4E) embryos Exp
protein was undetectable in tracheal cells ( Figs. 4D0, E0), whereas it
was present in Δ1 mutant embryos, as expected (Fig. 4C). This
result suggests that both exp135 and exp11 are null mutants.
Cysts form on unicellular and intracellular tracheal branches in exp
mutants
We examined the trachea in wild type and expmutant embryos
by staining for an apical membrane marker Crumbs (Crb) (Wodarz
et al., 1995). We observed bubble-like cysts in unicellular (LT, GB)
and intracellular (LG) branches, but not in multicellular branches
(DT). We also observed bubbles in DB and VB, but to a lesser
extent. Therefore, we focused our investigation on branches with a
stronger phenotype. In wild type embryos, Crb appeared as a
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single line in unicellular branches LT and GB (Fig. 1A, A0, D). Similar
lines were observed in intracellular branches such as LG (Fig. 1D).
In homozygous exp135 mutant trachea, we observed bubble-like
cysts on unicellular LT and GB (Fig. 1C, C0, E) as well as intracellular
LG (Fig. 1E). However, we did not observe cysts on intracellular
fusion branches (Fig. G–G″). Despite the appearance of cysts, the
tracheal network of exp mutants exhibited normal branching
patterns. Consistent with this observation, cysts were also
observed in exp11, exp135/exp11 and exp/Df(2R)BSC879 mutant
embryos (data not shown). The cyst phenotype in exp mutants
was similar to the defects observed in exp RNAi embryos (Fig. 1B, B0).
Cysts in exp mutants could also be visualized by another apical
membrane marker, Uninﬂatable (Uif), (Zhang and Ward, 2009),
which was used interchangeably with Crb to label the apical
membrane. To conﬁrm that the cyst phenotype was due to exp,
as opposed to PI31, CG8920, or background mutations, we ﬁrst
analyzed the Δ1 mutant strain, having deleted both PI31 and
CG8920. Δ1 mutants had wild-type-appearing tracheal branches
(Supplemental Fig. S1B–B2), and this indicates that the cyst
phenotype in exp mutants is caused by exp, but not other genes.
Fig. 1. exp mutants develop bubble-like cysts. Stage 16 wild type w1118, exp RNAi, and exp135 mutant embryos were immunostained for the apical membrane marker Crb.
Three hemisegments (5–7) are shown, with anterior to the left and dorsal up. (A) Crb outlines the apical membrane, appearing as a line (white arrowhead) in wild type
unicellular LT branches. Enlarged area is indicated in A0 . (B) LT branches have cysts (orange arrowheads) outlined by Crb in exp RNAi embryos. Enlarged area is indicated in B0 .
(C) Similar cysts (orange arrowheads) also develop in exp135 mutants embryos. Enlarged area is indicated in C0 . (D) Crb outlines unicellular branch GB and intracellular branch
LG. Both of them appear as a line (white arrowheads) in wild type embryos. (E) Both GB and LG have cysts (orange arrowheads) in exp135 mutants. Stage 16 w1118 and exp135
embryos carrying btl-Gal4 mCD8-GFP were immunostained for apical membrane Crb (red) and fusion cell nuclear marker Dys (blue) to analyze the fusion of LT branches.
mCD8-GFP (green) outlines the cell boundary. (F–F″) The fused LT branch (shown by white arrowheads) outlined by Crb (red) along with two fusion cells (blue) appears a
single line in w1118 embryo. (G–G″) The fused LT branch (shown by orange arrowheads) has normal wild type appearance without cysts in exp135 mutants. The white line in A
represents 10 μm in A, B, and C. The white line in D represents 5 μm in the rest of the panels.
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Furthermore, we expressed HA-exp-B throughout the trachea using
btl-Gal4 in an exp mutant background; it completely rescued the
tracheal phenotype in both exp135 and exp11 mutants (Supplemen-
tal Fig. S1C–C2). Thus, exp acts autonomously in the trachea to
control tube size. We use exp135 as the exp mutant in the following
experiments.
To quantify the cyst phenotype, we counted LT and GB cysts
and measured their diameter in 10 embryos (Supplemental
Table S2). The LT in each exp135 mutant tracheal segment con-
tained 2.470.2 cysts, with a diameter of 1.770.1 μm, whereas the
wild type trachea had no cysts and the diameter of the LT was
0.970.1 μm, which is consistent with published data (Beitel and
Krasnow, 2000). Each GB in exp135 had 2.570.1 cysts with a
diameter of 1.470.1 μm, whereas wild type GB had no cysts with
a diameter of 0.870.1 μm.
Unlike cranial vessels in zebraﬁsh, in which tube size is affected
by changes in cell number (Roman et al., 2002), alterations in cell
number do not normally play a role in tube-size regulation in the
Drosophila trachea (Beitel and Krasnow, 2000). To determine
whether cell number is involved in the exp phenotype, we counted
tracheal cell nuclei in tracheal segment 5 (Tr5) (N¼10) using
anti-Trh staining. There were 80.170.5 cells in Tr5 in wild-type
embryos verses 79.570.8 in exp mutant embryos. Thus, no
signiﬁcant difference was observed between exp mutant and
wild-type embryos. Therefore, exp is not required for the general
development of the trachea or tracheal branches, rather it speci-
ﬁcally controls cellular processes required for tube-size regulation.
Cysts are modiﬁed apical extracellular lumen in unicellular branches
and intracellular vacuole-like compartments in intracellular branches
To visualize cyst localization, we expressed membrane loca-
lized GFP (mCD8-GFP) driven by btl-gal4 to mark the cell boundary
in the entire trachea. In wild type trachea, the apical membrane
marker Crb appeared as a single line in GB (Fig. 5C–C″) and
intracellular tube LG (Fig. 5E–E″) within the cell boundary.
Similarly, cysts were also within the cell boundary in both GB
(Fig. 5D–D″) and LG (Fig. 5F–F″) in exp mutants. Intracellular tubes
are seamless tubes with cytoplasmic extensions in terminal
cells. Therefore, the cysts in LG are intracellular vacuole-like
compartments.
Fig. 2. Identity of the Drosophila exp gene. (A) Exp is a Smad-like protein containing an MH2 domain (gray box). Exp exists in two isoforms: Exp-A (1025 aa) and Exp-B (513
aa). The ﬁrst 477 amino acids (gray and black boxes), including the MH2 domain (55–222 aa), are identical in both isoforms. An anti-Exp antibody that recognizes both
isoforms was generated against an Exp fragment containing amino acids 233–477 (black line). The same region was used to generate an exp probe that recognizes both
isoforms. The region that was used to generate a speciﬁc exp-A probe recognizing exp-A is shown. (B) Exp belongs to a distinct subfamily of Smad-like proteins. The
alignment is represented by a phylogram generated using the neighbor-joining method. The tree demonstrated that Dro-Exp, Ano-AGAP007416, Dro-CG13183, and Ce-
C34E11.2C represent a distinct, evolutionarily conserved subfamily of Smad proteins that we named the Exp subfamily. Protein sequences of the MH2 domains of Smad
proteins were compared and aligned using ClustalW. The scale represents the fraction of nonidentical amino acid residues along each branch. The species designation
precedes each protein acronym (Dro, Drosophila melanogaster; Ano, Anopheles gambiae; Ce, Caenorhabditis elegans; Hum, human).
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To characterize cyst composition in unicellular branches, we
examined the distribution of apical and basolateral polarity mar-
kers. We examined the GB and found the apical membrane marker
Crb appears as a single line, determining the path of lumen,
whereas the basolateral marker Coracle (Cor) outlines the septate
junction in wild type control (Fig. 5A–A0 0 0). Similarly, Crb outlined
the cysts without overlapping with Cor in expmutants (Fig. 5B–B0 0 0),
suggesting cysts are modiﬁed apical compartments.
To determine whether the cysts in unicellular tubes are
modiﬁed apical extracellular lumen or intracellular vacuole-like
compartments, we analyzed the association of adherens junctions
(AJs) and cysts by staining embryos with the AJ marker Shotgun
(Shg; DE-Cadherin), the apical membrane marker Crb, and the
tracheal nuclear marker Trh. Unicellular branches are formed by a
line of cells with an end-to-end conﬁguration. The apical lumen in
unicellular tubes is extracellular and sealed by autocellular AJs
Fig. 3. Exp is localized throughout the cytoplasm of all tracheal cells. The localization of exp RNA and Exp protein was analyzed by ﬂuorescence in situ hybridization (FISH) to
an exp RNA probe and followed by immunostaining with anti-Exp antisera using whole mount wild type embryos. The exp probe and the anti-Exp antisera recognize both
isoforms. Sagittal views of tracheal segments 3–7 are shown, anterior is to the left and dorsal is up. Dorsal trunk (DT), transverse connective (TC), lateral trunk (LT), visceral
branch (VB), and dorsal branch (DB) were labeled. (A–G) exp RNA is expressed throughout the trachea from stages 12–17, but not at stage 11. Additionally, exp RNA is also
observed in epidermal cells at stage 16 and 17 (arrowheads). (A0–G0) The Exp protein has the exact same expression pattern as exp RNA. It is expressed in all tracheal cells
from stages 12–17, but not at stage 11. The Exp protein is also observed in epidermal cells at later stages (arrowheads). To visualize intracellular localization of Exp, wild type
embryos containing btl-Gal4 UAS-GAP-GFP were co-immunostained with anti-Exp (red in I, I″), anti-GFP that stains the cell membrane marker GAP-GFP (green in I, I0), and
anti-Trh that stains tracheal nuclei (blue in I), shown in DT cells. Exp is clearly localized throughout the cytoplasm (red in I) and also partially overlaps with the membrane
(yellow in I; arrowhead). (H) Exp protein is not detected in homozygous Df(2R)BSC879 embryos, which delete the entire exp gene locus and several other genes, even though
tracheal cells are present (labeled by Trh (red) in H0). (J) The 69KD Exp-B isoform is detected in cell lysate from wild type but not exp135 mutant embryos by Western blot
using anti-Exp antisera. However, the 139KD Exp-A is not detected in wild type. (K) exp-A RNA is not detected by FISH using an exp-A RNA probe that only recognizes the exp-
A isoform.
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(Ribeiro et al., 2004). In wild type embryos, anti-Shg labeled a
single line in GB along the apical membrane outlined by Crb
(Fig. 5G–G″″). In exp mutants, the cysts outlined by Crb were also
associated with a single line of Shg that outlines AJs (Fig. 5H–H0 0 0).
Almost all cysts we observed were associated with AJs. These
observations strongly suggest that cysts in unicellular tubes are
modiﬁed forms of apical extracellular lumen rather than intracel-
lular vacuole-like compartments.
exp Is required for the accumulation of luminal components in
unicellular and intracellular branches
To test whether exp is required for apical lumen formation, we
analyzed the composition of the luminal matrix in exp mutants.
The tested matrix components include: (1) Gasp (2A12), a chitin
binding protein, (2) Piopio, a zona pellucida (ZP) domain protein
(required to support migration of cells within the unicellular tube
during cell intercalation and cell junction remodeling) (Jazwinska
and Affolter, 2004), (3) Verm, a chitin modifying enzyme required
to limit tube elongation, and (4) chitin, which forms a transient
polysaccharide luminal matrix.
We observed defective accumulation of a subset of luminal
components in unicellular and intracellular branches where cysts
formed in expmutants. Chitin and Gasp failed to accumulate in the
lumen of unicellular and intracellular branches in exp mutants
(Fig. 6B″, B0 0 0) compared to control embryos (Fig. 6A″, A0 0 0). In
contrast to the defective accumulation of Gasp and chitin, the
luminal protein Piopio secretion appeared normal in exp mutants
(Fig. 6B0) relative to control embryos (Fig. 6A0). The normal
secretion of Piopio was consistent with the correct formation of
unicellular tubes through cell intercalation in exp mutants
(Fig. 5H–H0 0 0). In addition, the secretion of Verm was relatively
normal but slightly weaker in the LT in exp mutant (Fig. 6D)
compared to control embryos (Fig. 6C). Despite the accumulation
defects of luminal components in unicellular and intracellular
branches, the secretion of all luminal components tested, includ-
ing both 2A12 and chitin, was normal in multicellular branches in
exp mutants (Fig. 6B–B0 0 0, D). Thus, both cyst and lumen pheno-
types are restricted to unicellular tubes and intracellular branches,
rather than multicellular branches.
Exp negatively regulates RTK signaling to control tube size
The branch speciﬁc cyst phenotype in exp mutants is rather
unique. It was only observed in the double mutants of type III
RPTPs, Ptp4EPtp10D (Jeon and Zinn, 2009). Therefore, we speculate
Exp regulates tube size using similar mechanisms as RPTPs. We
predict two possibilities: (1) Exp is required to maintain RPTP
distribution in the trachea; (2) Exp does not directly regulate
RPTPs, but their targets. We analyzed Ptp10D distribution in exp
Fig. 4. Analysis of exp null mutants. (A) Genomic structure of the exp locus. The schematic diagram indicates the structure of the mRNA transcripts. Boxes indicate the exons,
connecting lines indicate the introns, protein coding sequences in the exons are ﬁlled with black, and untranslated regions are left white. Red lines with arrowheads indicate
the two neighboring genes, PI31 and CG8290. Brackets below the gene schematics indicate the region deleted in exp135, exp11, and Δ1. represents the P element insertion
site. (B) Exp protein (green) was localized to all tracheal cells in w1118 control embryos. (C) Exp protein was present in all tracheal cells in Δ1 mutant embryos that lack both
PI31 and CG8290, indicating that Δ1 was not mutant for exp. (D–E) Exp protein was not detected in exp135 and exp11 homozygous mutant embryos. (D0–E0) Trh staining (red)
revealed the presence of tracheal cells in both mutants.
E. Iordanou et al. / Developmental Biology 393 (2014) 93–108100
mutants. Ptp10D was selectively expressed at the apical mem-
brane in both wild type (Fig. 7C–C″) and exp mutant trachea
(Fig. 7D–D″), and no obvious difference was observed. The normal
distribution of Ptp10D in expmutants suggests that the expmutant
phenotype is likely not caused by the abnormal distribution of
RPTPs, since only the Ptp4EPtp10D double mutant shows a cyst
phenotype.
We then tested the idea that Exp has a similar function to RPTPs to
suppress RPTP targets. If that is the case, then Exp overexpression
could potentially suppress the cyst phenotype caused by the over
activated RPTP targets in Ptp4EPtp10Dmutants. As expected, when we
overexpressed exp in the trachea with btl-Gal4 in a Ptp4EPtp10D
double mutant background, the cyst phenotype was signiﬁcantly
reduced in LT and GB (Fig. 7B, B1, E) compared to Ptp4EPtp10D alone
(Fig. 7A, A1). As the number of LG cysts is variable, we qualitatively
assessed the effects of exp expression on LG bubbles. The diameter of
the LG bubble was also reduced (Fig. 7A2, B2). These results suggest
that Exp negatively regulates RPTP targets to control tube size.
Type III RPTPs negatively regulate downstream RTK signaling
(Matozaki, et al. 2010). Multiple overactive RTK signaling pathway
components (EGFR, Btl, Pvr) contribute to cyst formation in
Ptp4EPtp10D mutants (Jeon et al., 2012). Among them, EGFR and
Btl signaling play more important roles. To further test the idea that
Exp downregulates RTK signaling to control tube size, we either
increased or decreased EGFR or Btl signaling components in exp
mutants and analyzed their effects on cyst phenotype. The EGFR-CA
transgene carries the Elp mutation, which leads to constitutive
receptor activation. The Btl-CA construct was engineered with a
lambda receptor dimerization domain in the N-terminus, which
forces ligand-independent dimerization, therefore activating the
receptor. The EGFR-DN or Btl-DN constructs signiﬁcantly reduce or
eliminate RTK activity by dimerizing with wild type receptors,
forming inactive complexes. When we expressed CA or DN RTK
constructs in a wild type background, EGFR-CA and Btl-CA caused
extra branching, whereas EGFR-DN and Btl-DN led to shorter GBs
without generating cyst phenotypes or affecting tracheal branching
in general (data not shown). These observations of wild type
trachea were consistent with the previous report (Jeon et al.,
2012). We then expressed CA or DN RTK constructs in exp mutant
trachea and quantitatively analyzed the cyst phenotype in unicel-
lular LT and GB, and qualitatively analyzed cysts in intracellular LG.
EGFR-CA in exp mutant trachea signiﬁcantly enhanced cyst
Fig. 5. Cysts are apical compartments within the cell boundary in unicellular and intracellular branches in exp mutants. (A–B0 0 0) Stage 15 w1118 and exp135 embryos were
immunostained with the apical membrane marker Crb, basolateral membrane marker Cor, and tracheal nuclei marker Trh, to visualize apical-basal polarity in wild type and
exp135 mutant embryos. Unicellular branch GBs were shown. Both Crb (green) and Cor (red) appear as single lines without overlapping in wild type embryos (A–A0 0 0).
Similarly, cysts outlined by Crb do not overlap with Cor in exp135 mutant embryos (B–B0 0 0), indicating that cysts are apical compartments. (G–H0 0 0) Stage 15 w1118 and exp135
embryos containing btl-Gal4 mCD8-GFP that outlines the cell boundary were immunostained for Crb and the AJ marker Shg. Shg (blue) labels a line of autocellular junctions
along the apical membrane (red) in wild type GB (G–G0 0 0). Similarly, Shg (blue) labels a line of autocellular junctions despite cyst (red) formation in exp135 embryos,
suggesting that cysts are part of the extracellular lumen in unicellular branches (H–H0 0 0). (C–F″) Stage 15 w1118 and exp135 embryos containing btl-Gal4 mCD8-GFP were
immunostained for Crb and the cell membrane marker GFP. In wild type embryos, Crb (red) appears as a line within the cell boundary marked by mCD8-GFP (green) in
unicellular branch GB (C–C″) and intracellular branch LG (E–E″). Similarly in exp135 mutant embryos, cysts (white arrowheads) in GB (D–D″) and LG (F–F″) are also within the
mCD8-GFP labeled cell boundary. Nuclei were labeled by asterisks.
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phenotype in LT, GB and LG (Fig. 8D, D1, D2, Supplemental Table S2).
LT cysts were expanded from 1.7 mm to 2.5 mm (52% increase), GB
cysts were expanded from 1.4 mm to 2.5 mm (58% increase). LT cyst
number was increased from 2.4 to 3.3, and GB cyst number from
2.5 to 4.0. Similarly, Btl-CA also enhances the cyst phenotype, but
to a much lesser extent (Fig. 8F, F1, F2, Supplemental Table S2).
Conversely, Btl-DN drastically suppressed the cyst phenotype,
reducing cyst number to nearly zero in GB (Fig. 8E–E2, Supple-
mental Table S2). Likewise, EGFR-DN also considerably rescued the
cyst phenotype (Fig. 8C–C2, Supplemental Table S2). Extra branch-
ing by EGFR-CA or Btl-CA expression (arrows in Fig. 8D and F)
and extension defects in GB by EGFR-DN or Btl-DN expression
(Fig. 8C1, E1) were observed in exp mutants as in wild type.
However, this did not affect analysis of the cyst phenotype. Thus,
these genetic interaction assays indicate Exp is a negative regulator
of RTK signaling.
Two downstream pathways of RTK signaling, MAP kinase pathway
and Rho pathway, are implicated in cyst formation in Ptp4EPtp10D
double mutants (Jeon et al., 2012). We expect that these two pathways
also contribute to the exp phenotype, and we tested their input to the
cyst phenotype in GB and LG. Activation of the MAP kinase pathway is
mediated by Raf (MAP kinase kinase kinase, MAPKKK) and MEK
(MAP kinase kinase, MAPKK), which leads to dual phosphorylation
and activation of Erk (MAP kinase, MAPK) (Reich et al., 1999; Ohshiro
et al., 2002). Raf is a serine/threonine kinase. Expression of activated
Raf kinase, called Ph1-CA (Brand and Perrimon, 1994), in the wild type
trachea caused extra branching but did not generate any cysts as
described earlier (Jeon et al., 2012). However, it signiﬁcantly enhanced
the cyst phenotype in exp mutant trachea in both GB and LG (Fig. 9C,
C1, Supplemental Table S2). Extra branching occurred sometimes
(arrow in Fig. 9C). This result indicates that the MAP kinase pathway
contributes to cyst phenotype in exp mutants.
The Drosophila Rho family has several components: one Rho, three
Rac, and one Cdc42 (Johndrow et al., 2004). To evaluate the contribu-
tion of the Rho pathway to the cyst phenotype, we ﬁrst expressed CA
or DN constructs of Rho pathway components (Rho1, Rac1, Cdc42)
in a wild type background. Similar to what was described earlier (Jeon
et al., 2012), Rac1-CA severely disrupted tracheal development; Rho1-
CA and Cdc42-CA expression caused fusion defects in DT and LT and
extension defects in GB; Rac1-DN caused GB extension defects; Cdc42-
DN caused LT fusion defects; Rho1-DN did not cause signiﬁcant
branching defects. However, none of these constructs led to the cyst
phenotype (data not shown). We then expressed these constructs,
which did not cause severe trachea developmental defects, in exp
mutant trachea, and analyzed their effect on the cyst phenotype. Wild
type level defects in branching and fusion occurred in expmutants, but
this did not limit the observation of cysts. Rho1-CA enhanced cyst
phenotype in both GB and LG (Fig. 9D, D1, Supplemental Table S2)
whereas Cdc42-CA slightly reduced, rather than enhanced, the cyst
phenotype (data not shown). Both Rac1-DN and Rho1-DN partially
suppressed the cyst phenotype in GB (Fig. 9E, F, Supplemental Table
S2) and in LG (Fig. 9E1, F1, Supplemental Table S2), whereas Cdc42-DN
did not have an obvious effect (Fig. 9G, G1, Supplemental Table S2).
Therefore, through mainly Rac1 and Rho1, the Rho pathway also
contributes to cyst formation in exp mutants. Taken together, these
genetic interaction assays strongly suggest that Exp downregulates
RTK signaling (EGFR, Btl) through two downstream pathways, MAP
kinase and Rho, to control tube size.
Exp does not regulate TGF-β signaling to control tube size
Exp is a Smad-like protein containing a MH2 domain, which
usually functions as a regulator (such as Dad) of TGF-β (DPP)
signaling (Kamiya et al., 2008). To test the contribution of TGF-β
signaling in the exp mutant phenotype, we increased or decreased
the signaling components in an exp mutant background and
Fig. 6. Luminal Gasp (2A12) and chitin fail to accumulate in unicellular and
intracellular branches that develop cysts. (A–B0 0 0) Stage 16 wild type w1118 and
exp135 embryos were stained with anti-Gasp (MAb 2A12) (blue), chitin probe (red),
and anti-Piopio (green). (A–A0 0 0) In w1118 embryos, Gasp (2A12), chitin, and Piopio
accumulate in the lumen of all branches. (B–B0 0 0) In exp135 mutant embryos, Piopio
accumulates in all branches like in wild type. However, Gasp (2A12) and chitin only
accumulate in the lumen of DT but not other branches. (C, D) Similar to wild type
embryos, Verm is secreted to the lumen in all branches in exp135 mutants. However,
in LT, Verm (orange arrowhead) in exp135 mutants is slightly weaker compared to
wild type LT (white arrowhead).
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analyzed their effect on the cyst phenotype. In Drosophila, Thick
vein (Tkv) and Punt trans-membrane serine-threonine kinase
receptors are required in concert to transduce the TGF-β (DPP)
signal by phosphorylating Mad. The phosphorylated Mad then
binds to the common-mediator Medea and enters the nucleus to
regulate target gene expression. Overexpression of a constitutively
active form in wild type trachea, Tkv-Q253D, leads to defective DT
formation; numerous cells migrate dorsally (Affolter et al., 1994;
Vincent et al., 1997; Llimargas, 2000). In punt135 mutants, all dorsal
branches are absent, and GB extension defects are also occasion-
ally observed (Affolter et al., 1994; Vincent et al., 1997; Llimargas,
2000). Tkv-Q253D overexpression in exp mutant trachea caused
defects in DT formation, as expected; however, it did not have any
effect on the cyst phenotype in LT, GB, and LG (Fig. 10C–C2).
Similarly, despite no DB formation, punt135 exp double mutants
showed no obvious changes in cyst phenotype (Fig. 10B–B2).
To further rule out the possibility that Exp functions as a positive or
a negative regulator of TGF-β signaling, we expressed exp in gain of
function or loss of functionmutants of TGF-β (DPP) signaling, and then
analyzed their effect on branch speciﬁc migration defects in these
mutants. Constitutively active TGF-β (DPP) signaling in Tkv-Q253D
overexpressed embryos have defects in DT formation (Fig. 10E). If Exp
negatively regulates TGF‑β signaling, then exp overexpression likely
suppresses this defect. However, we did not observe a reduced DT
Fig. 7. Exp expression suppresses cyst phenotype in Ptp4EPtp10D double mutants, and Exp is not required for the distribution of Ptp10D. Stage 16 embryos were stained with
anti-Uif to label the tracheal apical membrane and imaged using confocal microscopy. LT in tracheal segments 5–6 were shown, GB in tracheal segment 6 was shown. (A–B2)
Expression of HA-Exp-B in Ptp4EPtp10D embryos signiﬁcantly reduced cyst size in LT (B), GB (B1) and LG (B2) compared to cysts in Ptp4EPtp10D embryos (A, A1, A2).
In addition, TC/LT branch junction cyst size was also signiﬁcantly reduced. White arrowheads point to LT and GB cysts and orange arrowheads point to TC/LT junction cysts.
Quantiﬁcation of LT and GB cysts is shown by the bar graph (E). Single GB stained with anti-Ptp10D (green) and the apical membrane marker Uif (red) in wild type (C–C″) and
exp135 mutant embryos (D–D″) were shown. Ptp10D (C–C0) was localized at the apical membrane labeled with Uif (C″) in wild type embryos. Similarly, Ptp10D (D–D0) was
also localized around cysts outlined with Uif (D″). The white line in B represents 10 μm in A and B. The white line in A1 represents 10 μm in the rest of the panels.
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formation defect (Fig. 10F). In TGF-β (DPP) loss of function mutant
punt135, all DBs did not form (Fig. 10G). If Exp functions as a positive
regulator of TGF-β signaling, overexpression of Exp is expected to
suppress the DB migration defect in punt mutants. Again, no obvious
change was observed (Fig. 10H). Taken together, these results strongly
suggest that Exp does not function as a typical Smad protein to
mediate TGF-β signaling to control tube size.
Discussion
In this paper, we analyzed the function of Exp, a novel
Smad-like protein in tube-size regulation. It is expressed in all
tracheal cells, yet the bubble-like cyst phenotype of exp mutants
was only observed in unicellular and intracellular branches, but not
multicellular tubes and fusion tubes. These tubes differ in their shape
changes during development and cellular coordination around the
lumen. The lumen in unicellular tubes is an extracellular compart-
ment that is sealed by an autocellular junction, whereas the lumen in
intracellular tubes is a cytoplasmic extension without a cell junction.
Fusion tubes are formed by two donut shaped cells connecting
neighboring branches. The lumen in multicellular tubes is formed
by several cells connected by intercellular junctions. During tracheal
development, multicellular branches only increase their size, without
dramatic changes in cell shape and the apical membrane. However,
unicellular and intracellular branches radically change cell shapes,
Fig. 8. Effects of dominant negative (DN) and constitutively active (CA) receptor tyrosine kinase (EGFR, Btl) mutants on cyst phenotype in exp mutants. Stage 16 embryos
were stained with anti-Uif to label the apical membrane. The tracheal speciﬁc driver btl-Gal4 was used to express all mutant UAS-RTK constructs in exp135 mutants. EGFR-CA
expression in exp135 mutants greatly enhanced the cyst phenotype in LT (D), GB (D1), and LG (D2) compared to exp135 mutants (B, B1, B2). Extra branching was observed
(arrows in D). To a lesser extent, Btl-CA also enhanced the cyst phenotype (F–F2). EGFR-DN signiﬁcantly reduced cysts in LT (C) and partially suppressed cysts in GB (C1) and
LG (C2). Btl-DN dramatically reduced the cyst phenotype in all branches analyzed (E–E2), and almost restored the phenotype to wild type level (A–A2). The thick white line
in A represents 10 μm in panels A–F. The thick white line in A1 represents 10 μm in the rest of the panels. The thin white lines indicate the beginning and the end of each GB
in A1–F1, and the beginning of LG in A2–F2.
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which require drastic apical membrane expansion. This phenomenon
may explain why bubbles are only observed in unicellular and
intracellular, but not multicellular tubes.
Unexpectedly, we did not observe bubbles in fusion cells that also
undergo signiﬁcant cell shape changes during branch fusion. The
fusion process is a dynamic cellular process involving cell migration,
adhesion, vesicle trafﬁcking, cytoskeleton rearrangement, and mem-
brane fusion (Lee and Kolodziej, 2002). We speculate that fusion cell
expressed genes may be involved in the regulation of tube size in
fusion branches, as occurs with speciﬁc genes involved in various
aspects of branch fusion. For example, escargot and dysfusion are
involved in the adhesion between two fusion cells, whereas dead end
regulates intracellular trafﬁcking in lumen formation between two
fusion cells (Tanaka-Matakatsu et al., 1996; Jiang and Crews, 2003;
Jiang et al., 2007). However, genes involved in tube-size regulation of
fusion branches have yet to be discovered. Fusion cell expressed genes
have been identiﬁed, such as CG13196 and CG15252, with their roles
in branch fusion remaining to be investigated (Jiang et al., 2010). These
genes may work redundantly with exp to further ensure the proper
tube size in fusion branches. Therefore, the lack of bubbles in fusion
cells of exp mutants is likely due to the presence of these genes.
Our results show Exp does not genetically interact with TGF-β
signaling to regulate tube size. This result is unexpected because
Exp is a Smad-like protein and Smads are well known intracellular
mediators of TGF-β signaling (Shi, 2001). TGF-β signaling is
implicated in the speciﬁcation of tracheal branches in Drosophila
(Chen et al., 1998) and regulation of cell numbers in cranial vessels
of zebraﬁsh (Roman et al., 2002). Our genetic interaction assays
suggest that Exp is neither a positive nor negative regulator of
TGF-β signaling. Additionally, TGF-β signaling did not contribute
to the cyst phenotype in exp mutants. Consistent with this, in exp
mutant embryos, neither branch identity nor cell number was
altered. Thus, this novel Smad does not function as a typical Smad
to regulate TGF-β signaling. Rather, our genetic interaction assays
strongly suggest that Exp interacts with RTK signaling to control
tube size. The strong suppression of the cyst phenotype in exp
mutants by expressing EGFR-DN and Btl-DN suggests that Exp
could negatively regulate these receptors. Exp is cytoplasmic/
membrane protein with a MH2 protein interacting domain; there-
fore, it is possible that Exp directly or indirectly interacts with the
cytoplasmic domains of the receptors to regulate their activities.
Interestingly, the Drosophila protein interaction database shows
Exp as interacting with only one protein, CG11275. In addition,
CG11275 interacts with Pointed, Stumps, and Vps36. Stumps and
Pointed are components of RTK signaling, whereas Vps36 is
involved in protein trafﬁcking at the early endosome (Scholz
et al., 1993; Imam et al., 1999; Herz et al., 2009). Therefore, we
cannot exclude the possibility that Exp acts on other RTK signaling
components, and/or regulates vesicular trafﬁcking to control tube
size. It will be interesting to investigate whether the closest C.
elegans homolog, Ce-c34e11.2c, regulates RTK but not TGF-β
signaling, and whether Exp protein interactions are conserved in
Ce-c34e11.2c. If Ce-c34e11.2c functions similarly, Exp might deﬁne
a family of non-TGF-β signaling Smads.
Expression of multiple RTK-CA transgenes could not reproduce the
cyst phenotype (Jeon et al., 2012). This indicates that Exp also
Fig. 9. Effect of Map kinase and Rho pathway mutants on cyst phenotype in exp mutants. Stage 16 embryos were stained with anti-Uif to label the apical membrane. The
tracheal speciﬁc driver btl-Gal4 was used to express CA or DN constructs in exp135 mutants. Images of GB (A–G) and LG (A1–G1) stained with anti-Uif are shown. Strong
enhancement of the exp phenotype in both GB (C) and LG (C1) was observed with Raf-CA expression. Extra branching was observed (arrow in C). Partial enhancement in GB
(D) and LG (D1) was observed by Rho1-CA expression. Strong suppression of the GB cyst phenotype was observed by Rac1-DN (E) and Rho1-DN (F). GB extension defect was
observed by Rac1-DN (E). Partial suppression of the LG cyst phenotype was observed by Rac1-DN (E1) and Rho1-DN (F1). No obvious suppression of GB (G) and LG (G1) cysts
was observed by Cdc42-DN. The thick white line in A represents 10 μm in panels A–G. The thick white line in A1 represents 10 μm in the rest of panels. The thin white lines
indicate the beginning and the end of each GB in A–F, and the beginning of LG in A1–F1.
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regulates other unknown pathways or cellular processes (such as
vesicular trafﬁcking) that cooperate with RTK signaling to control
tube size. The identiﬁcation of Exp interacting proteins will further
reveal the role of this novel Smad protein in tube-size regulation.
Elucidating the function of Exp will provide novel insights into tube-
size regulation as well as the role of Smad proteins in general.
Conclusion
This work provides a clear understanding of the role of
Expansion, a novel Smad protein, in the regulation of Drosophila
tracheal tube diameter. Exp is required for the restriction of tube
dilation in both unicellular and intracellular branches. We used
Fig. 10. TGF-β (Dpp) signaling and Exp do not genetically interact. (A–C2) Stage 16 embryos were stained with anti-Uif to label the apical membrane in the trachea. No
obvious enhancement or suppression of the cyst phenotype was observed in LT (B), GB (B1), and LG (B2) in exp punt double mutant embryos compared to expmutants alone
(A–A2). Similarly, enhancing TGF-β signaling by TKV253 QD (TKV-active) expression in an expmutant background using btl-Gal4 did not change the cyst phenotype in LT (C),
GB (C1), and LG (C2). The thick white line in A represents 10 μm in panels A–C. The thick white line in A1 represents 10 μm in A1–C2. The thin white lines indicate the
beginning and the end of each GB in A1–C1, and the beginning of LG in A2–C2. (D–H) Stage 15 embryos were stained with anti-Uif to label the apical membrane in the
trachea. TkvQD expression in trachea caused DT migration defects (arrowheads) in (E) compared to control (D). Overexpression of both Exp and TkvQD in trachea had similar
DT migration defect (F). DB migration defect was observed in punt135 mutant embryos (G). Similarly, DB migration defect was still observed when Exp was expressed in
punt135 mutants (H). The thick white line in D represents 10 μm in D–H.
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genetic interaction assays to demonstrate that Exp regulates RTK
signaling to control tube size. In addition, genetic interaction
assays between Exp and TGF-β signaling components strongly
suggest that, unlike typical Smad proteins, Exp does not regulate
TGF-β signaling to control tracheal tube size. In general, the
understanding of tube size regulation is still limited; however,
this study provides a signiﬁcant contribution to this area of
research by elucidating a novel mechanism for tube diameter
expansion.
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